These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. TREM2 in Neurodegenerative Diseases. Jay TR; von Saucken VE; Landreth GE Mol Neurodegener; 2017 Aug; 12(1):56. PubMed ID: 28768545 [TBL] [Abstract][Full Text] [Related]
69. TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges. Zgorzynska E Mol Cell Neurosci; 2024 Mar; 128():103917. PubMed ID: 38244651 [TBL] [Abstract][Full Text] [Related]
70. Precise gene delivery systems with detachable albumin shell remodeling dysfunctional microglia by TREM2 for treatment of Alzheimer's disease. Wang P; Yang P; Qian K; Li Y; Xu S; Meng R; Guo Q; Cheng Y; Cao J; Xu M; Lu W; Zhang Q Biomaterials; 2022 Feb; 281():121360. PubMed ID: 34991033 [TBL] [Abstract][Full Text] [Related]
71. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice. Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586 [TBL] [Abstract][Full Text] [Related]
72. TREM2 - a key player in microglial biology and Alzheimer disease. Ulland TK; Colonna M Nat Rev Neurol; 2018 Nov; 14(11):667-675. PubMed ID: 30266932 [TBL] [Abstract][Full Text] [Related]
73. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-β pathology. Mancuso R; Fattorelli N; Martinez-Muriana A; Davis E; Wolfs L; Van Den Daele J; Geric I; Premereur J; Polanco P; Bijnens B; Preman P; Serneels L; Poovathingal S; Balusu S; Verfaillie C; Fiers M; De Strooper B Nat Neurosci; 2024 May; 27(5):886-900. PubMed ID: 38539015 [TBL] [Abstract][Full Text] [Related]
74. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways. Ibanez KR; McFarland KN; Phillips J; Allen M; Lessard CB; Zobel L; De La Cruz EG; Shah S; Vo Q; Wang X; Quicksall Z; Ryu D; Funk C; Ertekin-Taner N; Prokop S; Golde TE; Chakrabarty P Alzheimers Res Ther; 2022 Jul; 14(1):104. PubMed ID: 35897046 [TBL] [Abstract][Full Text] [Related]
75. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease. Zhao P; Xu Y; Jiang L; Fan X; Li L; Li X; Arase H; Zhao Y; Cao W; Zheng H; Xu H; Tong Q; Zhang N; An Z Sci Transl Med; 2022 Sep; 14(661):eabq0095. PubMed ID: 36070367 [TBL] [Abstract][Full Text] [Related]
76. TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4. Gratuze M; Schlachetzki JCM; D'Oliveira Albanus R; Jain N; Novotny B; Brase L; Rodriguez L; Mansel C; Kipnis M; O'Brien S; Pasillas MP; Lee C; Manis M; Colonna M; Harari O; Glass CK; Ulrich JD; Holtzman DM Neuron; 2023 Jan; 111(2):202-219.e7. PubMed ID: 36368315 [TBL] [Abstract][Full Text] [Related]
79. Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia. Reich M; Paris I; Ebeling M; Dahm N; Schweitzer C; Reinhardt D; Schmucki R; Prasad M; Köchl F; Leist M; Cowley SA; Zhang JD; Patsch C; Gutbier S; Britschgi M Front Immunol; 2020; 11():617860. PubMed ID: 33613545 [TBL] [Abstract][Full Text] [Related]
80. Pathological Roles of INPP5D in Alzheimer's Disease. Chu YN; Akahori A; Takatori S; Tomita T Adv Exp Med Biol; 2023; 1423():289-301. PubMed ID: 37525057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]